GDS Holdings Limited ADS GDS reports blowout Q4 2025 EPS results 55 percent year over year revenue growth minor stock gain ZBH Zimmer Biomet Holdings Inc reports Q4 2025 earnings per share that align perfectly with Wall Street consensus estimates MDXH MDxHealth SA Ordinary Shares Q4 2025 revenue grows 198 percent year over year shares rise 176 percent despite EPS miss VYNE Therapeutics Inc VYNE beats Q4 2025 EPS expectations significantly yet shares edge slightly lower in todays trading Stocks Climb as Oil Retreats and Dollar Weakens on Iran Diplomacy Optimism SpaceX Starship Faces Technical Challenges in Race for Lunar Mission Milestones EOG Resources Surges in Q1 Key Drivers Behind the Energy Stocks Rally Bitcoin Drops to 745k Poised for Weekly Loss Amid Geopolitical Tensions South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags SRXH Q2 2025 Earnings EPS Loss of 074 Amidst Stock Decline FIS Q1 2026 Earnings EPS Surpasses Estimates by 464 as Stock Moves Lower SSM Q1 2026 Earnings Loss per Share of 059 as PreRevenue Development Continues CVI Q1 2026 Earnings Deep Losses and Wide Miss Signal Challenging Refining Environment PTCT Q1 2026 Earnings Narrower Loss Surprises Estimates as Stock Dips Slightly Sabesp SBS Edges Lower Analyzing Support and Resistance Levels Amidst Modest Decline Bgin Blockchain BGIN Slides 359 Key Support Level Tested Heron Therapeutics HRTX Slides to 086 as Selling Pressure Persists Cardinal Health CAH Holds Steady Near Key Support After Slight Decline STRD Preferred Stock Holds Steady Near 7350 as Support and Resistance Levels Come into Focus Sensex Stocks with up to 40 Upside Potential Analysts Identify Key Names Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline CapsoVision Inc CV Advances 118 as Price Moves Toward Resistance